106 related articles for article (PubMed ID: 3828787)
1. Brain dopamine receptor levels elevated in canine narcolepsy.
Bowersox SS; Kilduff TS; Faull KF; Zeller-DeAmicis L; Dement WC; Ciaranello RD
Brain Res; 1987 Jan; 402(1):44-8. PubMed ID: 3828787
[TBL] [Abstract][Full Text] [Related]
2. Narcolepsy: biogenic amine deficits in an animal model.
Mefford IN; Baker TL; Boehme R; Foutz AS; Ciaranello RD; Barchas JD; Dement WC
Science; 1983 May; 220(4597):629-32. PubMed ID: 6188216
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic cholinergic receptors and the canine model of narcolepsy.
Kilduff TS; Bowersox SS; Kaitin KI; Baker TL; Ciaranello RD; Dement WC
Sleep; 1986; 9(1 Pt 2):102-6. PubMed ID: 3704431
[TBL] [Abstract][Full Text] [Related]
4. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Hall H; Sedvall G; Magnusson O; Kopp J; Halldin C; Farde L
Neuropsychopharmacology; 1994 Dec; 11(4):245-56. PubMed ID: 7531978
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain.
De Keyser J; De Backer JP; Ebinger G; Vauquelin G
J Neurol Sci; 1985 Nov; 71(1):119-27. PubMed ID: 2935593
[TBL] [Abstract][Full Text] [Related]
6. Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain.
Mefford IN; Foutz A; Noyce N; Jurik SM; Handen C; Dement WC; Barchas JD
Brain Res; 1982 Mar; 236(2):339-49. PubMed ID: 6175382
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-receptor autoradiography of human narcoleptic brain.
Aldrich MS; Hollingsworth Z; Penney JB
Neurology; 1992 Feb; 42(2):410-5. PubMed ID: 1736175
[TBL] [Abstract][Full Text] [Related]
8. Increased brain dopamine and dopamine receptors in schizophrenia.
Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amine concentrations in the brains of normal and narcoleptic canines: current status.
Faull KF; Zeller-DeAmicis LC; Radde L; Bowersox SS; Baker TL; Kilduff TS; Dement WC
Sleep; 1986; 9(1 Pt 2):107-10. PubMed ID: 3704432
[No Abstract] [Full Text] [Related]
10. CNS monoamines and their metabolites in canine narcolepsy: a replication study.
Miller JD; Faull KF; Bowersox SS; Dement WC
Brain Res; 1990 Feb; 509(1):169-71. PubMed ID: 1689603
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of dopamine and its metabolites in brain microdialysates: method combining freeze-drying with liquid chromatography-tandem mass spectrometry.
Syslová K; Rambousek L; Kuzma M; Najmanová V; Bubeníková-Valešová V; Slamberová R; Kačer P
J Chromatogr A; 2011 May; 1218(21):3382-91. PubMed ID: 21397906
[TBL] [Abstract][Full Text] [Related]
12. [Participation of the dopamine of the striatum and the nucleus accumbens in the formation of aggressive and submissive behaviors in mice].
Kudriavtseva NN; Nikulina EM; Popova NK
Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1168-70. PubMed ID: 3245329
[No Abstract] [Full Text] [Related]
13. Brain dopamine D-2 receptors in senile dementia.
Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
J Neural Transm; 1986; 65(1):51-62. PubMed ID: 2870131
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation.
Joyce JN; Loeschen SK; Marshall JF
Brain Res; 1985 Jul; 338(2):209-18. PubMed ID: 3161583
[TBL] [Abstract][Full Text] [Related]
15. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
Nishino S; Fujiki N; Ripley B; Sakurai E; Kato M; Watanabe T; Mignot E; Yanai K
Neurosci Lett; 2001 Nov; 313(3):125-8. PubMed ID: 11682143
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents.
Ongali B; Ase AR; Hébert C; Amdiss F; Reader TA
Synapse; 2000 Jul; 37(1):1-15. PubMed ID: 10842346
[TBL] [Abstract][Full Text] [Related]
17. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
Guldberg HC; Yates CM
Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
[TBL] [Abstract][Full Text] [Related]
18. Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
Bridge TP; Kleinman JE; Karoum F; Wyatt RJ
Neuropsychobiology; 1985; 14(2):57-61. PubMed ID: 4088459
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.
Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1992 Sep; 262(3):1085-94. PubMed ID: 1527715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
